fbpx
News
October 8, 2019

In the News Today – October 8, 2019

“Erosion Of Bristol-Myers Test In Class Actions Is Misguided”: Three attorneys from the Skadden Arps Slate Meagher & Flom law firm said “there is no policy justification” for treating individual lawsuits and class actions differently when it comes to applying the U.S. Supreme Court’s Bristol-Myers Squibb decision on jurisdiction. (Law360)

Cookie Notice

By clicking “I Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

Cookie Notice

By clicking “I Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Review Settings